See Lady Liv, the first AI avatar born from real people’s lived experiences with dementia. Watch ‘Liv’ help those recently diagnosed, by answering questions only a peer who shares the experience of Alzheimer’s would know.
Leqembi is an FDA-Approved Alzheimer’s treatment. Hospital infusions take an hour each. 2025 is looking to see a new 15-second autoinjector version. For some, it should even work at home.
Why are some of the new anti-Alzheimer’s antibodies better than others? With the FDA’s approval of Lecanemab and Donanemab, it’s worth staying on top of this topic’s latest research.
The 2 newest Alzheimer’s drugs, Leqembi (lecanemab) and Kisunla (donanemab) show promise, but many questions remain. Here are the three next ones.
A new Harvard study of 2,000 former NFL players shows one-third believe they have chronic traumatic encephalopathy (CTE), a neuropathological condition linked to repeated head trauma.
Right now, there are two FDA approved drugs to treat Alzheimer’s itself. Find out why Remternetug may soon get approval as a third, even better treatment.
Kisunla, the newest Alzheimer’s drug, is rapidly gaining acceptance around the world. Learn what it does and how to get it.
How do the new drugs Leqembi and Kisunla fight Alzheimer’s? Surprisingly, increases in amyloid-beta protein levels can explain the slowing of Alzheimer’s at least as well as the reduction in amyloid plaques.
Ely Lilly unveils new $1,000,000,000 facility for drugs including Kisunla for Alzheimer’s. New investment will enhance global medicine production, benefiting millions of patients worldwide
Diabetes and prediabetes are dementia risk factors. They affect 1 in 7 adults! Learn about new research to lower that risk with lifestyle and drugs.
FILL A MEMORY BOX with photos and memorabilia of a person with dementia, then position it by their door. See it re-orient them, trigger conversations, make a doorway one’s own, and mostly, stimulate memories of good times.
This week in the USA: Martin Luther King Jr. Day
LAW & MONEY: Get ahead of the legal & financial challenges of Alzheimer’s. This Fact Sheet is a great place to start.
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!
It looks like a sneeze cannot give anyone Alzheimer’s. While Alzheimer’s abnormal disease proteins do spread from cell-to-cell, they are not “infectious”. Check out the facts.
No spam, only news and updates.
